Suresh Pullela 

Chief Quality Officer*

Suresh Pullela joined Sardocor as VP of Quality Operations in January 2022.

Suresh has over 25 years of biotechnology and pharmaceutical industry experience across multiple therapeutic modalities (across early clinical to late stage/commercial companies). He has held roles in Quality Engineering/Validation, External Quality, and CMC Quality Technical Operations with the companies such as Genentech/Roche, Baxter BioScience (now Takeda), and PAREXEL.  In these roles he has worked on a variety of product transfers to multiple sites around the world (Europe, Asia, USA) resulting in multiple product approvals and launches (biologics and small molecules).

Suresh most recently served as Senior Director of Quality Assurance at Harpoon Therapeutics, which includes early to mid-stage T cell engager therapy portfolio across multiple cancer indications (listed on Nasdaq), most recently acquired by Merck. In addition, Suresh served as a consultant supporting FDA remediation activities. Before Harpoon, he spent 3 years at Ultragenyx where he was responsible for Quality oversight of Biologics programs spanning clinical and commercial stages of the development lifecycle resulting in approval of its first biologic enzyme replacement therapy in 2018.

Suresh holds a Bachelors in Engineering from Andhra University, India, and a Master of Science in Mechanical Engineering from North Carolina State University, Raleigh, NC.